Escitalopram clinical trials
Escitalopram is named as an intervention in 15 current clinical trials in our China, Canada, Austria, Germany, Spain, Italy, Denmark, Poland, Turkey, Mexico and South Korea registers. 11 are recruiting patients now. The most common phase is Not applicable. The sponsor with the most trials is Dr. Inge Winter (2). The most-studied condition is Major Depressive Disorder (MDD).
Where Escitalopram is approved
All regulators →Of the three regulators tracked here, the first to approve Escitalopram was Canada, on 14 Aug 2012.
From the regulators' own registers: FDA Drugs@FDA, the EMA medicines list and Health Canada's Notice of Compliance database. Dates are the first listed approval of a product containing only this substance; combination products and nationally authorised EU medicines are not counted.
What health systems spend on Escitalopram
All medicines →From NHSBSA Prescription Cost Analysis (Open Government Licence v3.0) and CMS State Drug Utilization Data. Both are gross amounts: neither system publishes its discounts or rebates per drug. Products combining several substances are not counted here.
How Escitalopram works
All drug targets →- Serotonin transporter inhibitor InhibitorTarget: SLC6A4 solute carrier family 6 member 4✓ In ChEMBL and the Guide to Pharmacology
- AgitationPhase 3
- Alzheimer diseasePhase 3
- AnxietyPhase 3
- Bipolar disorderPhase 3
- Breast cancerPhase 3
- Burning mouth syndromePhase 3
- Depressive disorderPhase 3
- Generalized anxiety disorderPhase 3
- Major depressive episodePhase 3
- Obsessive-compulsive disorderPhase 3
Mechanisms and diseases from ChEMBL via the Open Targets Platform (release 26.09), ChEMBL record CHEMBL1508, CC BY-SA 3.0. Targets checked against the IUPHAR/BPS Guide to PHARMACOLOGY (2026.3.1), ligand 7177, CC BY-SA 4.0. Trial phases are not approvals: approved uses are shown from the regulators' own records where we hold them.
Patient leaflets for Escitalopram
The package leaflet is the official guide for patients that comes with every medicine. These links go to the regulators that publish it.
- IEIreland: 39 products on the HPRA listEach product record links to the HPRA, which publishes the leaflet and SmPC.
- UKUnited Kingdom: Search MHRA ProductsPatient information leaflets and SmPCs for UK-licensed products.
- USUnited States: Search DailyMedFDA-approved labels, including patient and medication guides.
Leaflets differ between brands and countries; always read the one that comes with your own medicine. This is regulatory information, not medical advice.
Reference identifiers for Escitalopram
- ATC code
- N06AB10
- ChEMBL
- CHEMBL1508
- DrugBank
- DB01175
- PubChem CID
- 146570
- CAS number
- 128196-01-0
- FDA UNII
- 4O4S742ANY
- Wikidata
- Q423757
- Wikipedia
- Escitalopram
Codes that identify this medicine in other databases, from Wikidata (CC0), matched by its ChEMBL ID. The ATC code is the WHO classification of what the medicine is used for.
Trials by status
Trials by phase
Clinical trials of Escitalopram
15 trialsRegisters list studies that are recruiting, about to open, active but closed to enrolment, or enrolling by invitation. The UK and USA registers cover industry-sponsored studies only. Trial titles and statuses are copied from the registry as published.
Escitalopram across our data
Ireland · EU · USThe same active substance in our other registers, matched by its exact name. Each entry links to the register record it comes from.
Licensed in Ireland (HPRA)
39 single-substance products containing Escitalopram on the HPRA medicines list.
- Esciprex 10 mg film-coated tabletsRowex Limited, · PA0711/194/002 · Marketed
- Esciprex 15 mg film-coated tabletsRowex Limited, · PA0711/194/003 · Marketed
- Esciprex 20 mg film-coated tabletsRowex Limited, · PA0711/194/004 · Marketed
- Esciprex 5 mg film-coated tabletsRowex Limited, · PA0711/194/001 · Marketed
- Escitalopram 10 mg film-coated tabletsAccord Healthcare Ireland Ltd. · PA2315/086/002 · Marketed
Supply shortages
No entry for Escitalopram in the EMA, FDA or German BfArM shortage lists we track.
Conditions studied with Escitalopram
17 conditionsAll 17 conditions
| Condition (as registered) | Trials |
|---|---|
| Major Depressive Disorder (MDD) | 4 |
| Depression - Major Depressive Disorder | 3 |
| Major Depressive Disorder | 3 |
| Rumination | 1 |
| MDD | 1 |
| Bipolar Depression | 1 |
| Obsessive-Compulsive Disorder/High Compulsive Individuals | 1 |
| Healthy Individuals | 1 |
| Depressive Episodes | 1 |
| Healthy | 1 |
| Lactating Women on Select DOI | 1 |
| Breastfed Infants of Mothers on Select DOI | 1 |
| Chronic Kidney Disease (CKD) | 1 |
| Elderly | 1 |
| Outpatient | 1 |
| Dementia | 1 |
| Treatment Resistant Depression | 1 |
Sponsors
lead sponsor per trial| Lead sponsor | Trials |
|---|---|
| Dr. Inge Winter | 2 |
| Peking University | 1 |
| Central South University | 1 |
| Vigonvita Life Sciences | 1 |
| Gang Wang | 1 |
| Copenhagen University Hospital, Rigshospitalet | 1 |
| Poznan University of Medical Sciences | 1 |
| Medical University of Vienna | 1 |
| Mehmet Kemal Arikan | 1 |
| Nova Scotia Health Authority | 1 |
| Duke University | 1 |
| London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's | 1 |
| JHSPH Center for Clinical Trials | 1 |
| Chonnam National University Hospital | 1 |
By country register
A trial with sites in more than one country appears in each of those registers.
Related compounds
Questions about Escitalopram trials
How many clinical trials are testing Escitalopram?
15 current trials in our China, Canada, Austria, Germany, Spain, Italy, Denmark, Poland, Turkey, Mexico and South Korea registers name Escitalopram (also registered as ATC code: N06AB10) as a drug or biological intervention, as of the registry sync on 10 November 2026. Completed and withdrawn studies are not counted.
Are Escitalopram trials recruiting patients?
Yes. 11 of the 15 trials are recruiting: 3 with sites in China, 2 with sites in Canada, 3 with sites in Austria, 2 with sites in Germany, 2 with sites in Spain, 2 with sites in Italy, 1 with sites in Poland, 1 with sites in Turkey, 1 with sites in Mexico and 1 with sites in South Korea. Eligibility and site contacts are on each trial's record. Only the study team can confirm whether a patient is eligible.
Who sponsors Escitalopram clinical trials?
Dr. Inge Winter (2), Peking University (1), Central South University (1) and Vigonvita Life Sciences (1), among 14 lead sponsors in total. The number in brackets is how many trials each organisation leads.
Is Escitalopram licensed in Ireland?
Yes. The HPRA medicines list includes 39 single-substance products containing Escitalopram, for example Esciprex 10 mg film-coated tablets (Rowex Limited,). A licence does not mean a product is currently marketed or reimbursed; see each product's record.
Is there a Escitalopram shortage?
Not in the lists we track: Escitalopram has no entry in the EMA, FDA or German BfArM shortage registers as of their latest sync.
Where does this information come from?
Every trial, status, phase and sponsor on this page is copied from public ClinicalTrials.gov records by a daily sync. Nothing here describes how Escitalopram works or whether it is effective, and it is not medical advice.
How this page is built
Everything on this page is copied from public ClinicalTrials.gov registry records — it is not written from memory, and nothing here describes how Escitalopram works or whether it is effective. Each trial links to its own record so you can check it yourself.
- ClinicalTrials.gov (U.S. National Library of Medicine) ↗ Trial IDs, titles, intervention names and synonyms, phase, overall status, lead sponsor and conditions for every trial on this page
This page is built automatically: a daily sync job reads the registry records behind our country trial registers, collects every trial that lists Escitalopram (or a registered synonym) as a drug or biological intervention, and tabulates the registry fields directly. Placebos and generic comparators are excluded. There is no AI drafting and no per-compound editorial pass, and the page has not been clinically reviewed. The “last verified” date above is the timestamp of that sync, not a review date. Our general editorial approach is described in our editorial standards and corrections policy. The ClinicalTrials.gov data on this page was last retrieved on 10 Nov 2026. How every register is built: methodology · fixes we have made: corrections log.